Erratum: Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer (Cancer Cell (2017) 31(4) (532–548.e7)(S1535610817300600)(10.1016/j.ccell.2017.02.017))

Academic Article

Abstract

  • © 2017 Elsevier Inc. (Cancer Cell 31, 532–548; April 10, 2017) During the course of revising the manuscript and providing higher-magnification images, the authors inadvertently selected an incorrect image for Figure 4E (DU145 cells, lower right panel). This was a mistake in enlarging these images, and the initial submission did not contain this error. The correction to the image in Figure 4E does not affect the conclusions of the paper. This error has now been corrected here and in the article online. In the Supplemental Information, the images shown in Figure S3G were incorrect. These images were mistakenly duplicated from Figure S4B during preparation of the figures. Figure S3G has now been corrected here and in the Supplemental Information online. The text, the figure legends, and the conclusions of this article are not affected by this Correction. The authors apologize for any inconvenience that these errors in final figure revision/preparation may have caused.[Figure presented]
  • Published In

  • Cancer Cell  Journal
  • Digital Object Identifier (doi)

    Author List

  • Wang X; Qiao Y; Asangani IA; Ateeq B; Poliakov A; Cieślik M; Pitchiaya S; Chakravarthi BVSK; Cao X; Jing X
  • Start Page

  • 844
  • End Page

  • 847
  • Volume

  • 31
  • Issue

  • 6